【レポートの概要（一部）】
Table of Contents
PART 01: Executive summary
• Alternate therapies hinder the growth possibilities of approved therapies
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Highlights
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by product type
• Global mAbs market
• Global human insulin market
• Global clotting factors market
• Global EPO market
• Global human growth hormone market
PART 07: Market segmentation by therapy area
• Metabolic and endocrine disorders
• Hematopoiesis
• Fertility
• Cancer
• Autoimmune diseases
• Infectious diseases
• Protein vaccine
PART 08: Market segmentation by protein function
• Enzymatic and regulatory activity
• Special targeting activity
• Vaccines
• Protein diagnostics
PART 09: Geographical segmentation
• Protein therapeutics market in Americas
• Protein therapeutics market in EMEA
• Protein therapeutics market in APAC
PART 10: Market drivers
• Increased demand for mAbs
• Development of novel therapies using innovative technologies
• Availability of favorable reimbursement policies
PART 11: Impact of drivers
PART 12: Market challenges
• Complexities in manufacturing, storage conditions, distribution policies, and high cost
• Complicated regulatory framework
• Alternate therapies loom large
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Emergence of next-generation biologics
• Advent of biosimilars expected to improve the treatment rates
• Strategic alliances further boost the R&D efforts
PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2016
• Other prominent vendors
PART 16: Key vendor analysis
• F. Hoffmann-La Roche
• Novo Nordisk
• Amgen
• AbbVie
• Johnson & Johnson
• Merck
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Overview of protein therapeutics market 2016-2021
Exhibit 03: Key strategies in global protein therapeutics market
Exhibit 04: Global protein therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 05: Global protein therapeutics market 2016-2021 ($ billions)
Exhibit 06: Patent expirations of major biologics 2000-2030
Exhibit 07: Impact of factors affecting the market 2016 and 2021
Exhibit 08: Five forces analysis
Exhibit 09: Segmentation of global protein therapeutics market by product type
Exhibit 10: Market share of global protein therapeutics market by product type
Exhibit 11: Overview of global mAbs market
Exhibit 12: Annual treatment cost per patient for various drugs 2015
Exhibit 13: Global mAbs market: Present and future scenario
Exhibit 14: Global mAbs market 2016-2021 ($ billions)
Exhibit 15: Opportunity analysis of global mAbs market
Exhibit 16: Year-over-year (YoY) sales comparison of mAbs 2013-2015 ($ billions)
Exhibit 17: Market overview of human insulin
Exhibit 18: Global human insulin market 2016-2021 ($ billions)
Exhibit 19: Factors affecting global human insulin market
Exhibit 20: Opportunity analysis of global human insulin market
Exhibit 21: Revenues from the sales of top five products in insulin market 2013-2015 ($ billions)
Exhibit 22: Market overview of clotting factors
Exhibit 23: Global clotting factors market 2016-2021 ($ billions)
Exhibit 24: Opportunity analysis of global clotting factors market
Exhibit 25: Market overview of EPO
Exhibit 26: Global EPO market 2016-2021 ($ billions)
Exhibit 27: Globally approved EPO biosimilars
Exhibit 28: Opportunity analysis of global EPO market
Exhibit 29: Market overview of human growth hormone
Exhibit 30: Global human growth hormone market 2016-2021 ($ billions)
Exhibit 31: Opportunity analysis of global human growth hormone market
Exhibit 32: Segmentation of global protein therapeutics market by therapy area
Exhibit 33: Segmentation of global protein therapeutics market by protein function
Exhibit 34: Global protein therapeutics market: Segmentation by geography (2016-2021)
Exhibit 35: Global protein therapeutics market segmentation by region: Market growth lifecycle analysis 2016
Exhibit 36: Overview of protein therapeutics market in Americas
Exhibit 37: Protein therapeutics market in Americas 2016-2021 ($ billions)
Exhibit 38: Protein therapeutics market in Americas: Opportunity analysis
Exhibit 39: Overview of protein therapeutics market in EMEA
Exhibit 40: Protein therapeutics market in EMEA 2016-2021 ($ billions)
Exhibit 41: Protein therapeutics market in EMEA: Opportunity analysis
Exhibit 42: Overview of protein therapeutics market in APAC
Exhibit 43: Protein therapeutics market in APAC 2016-2021 ($ billions)
Exhibit 44: Protein therapeutics market in APAC: Opportunity analysis
Exhibit 45: mAb approvals by the US FDA and EMA 2010-2015
Exhibit 46: Advances in ADCs technology
Exhibit 47: Few of other technologies used in protein therapeutics
Exhibit 48: Impact of drivers
Exhibit 49: Approval process of biologicals versus biosimilars via Public Health Service Act (PHSA) in US
Exhibit 50: Few of CAM therapies used for autoimmune and inflammatory diseases
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Overview of next-generation antibodies
Exhibit 53: Oral insulin pipeline portfolio
Exhibit 54: Few of the biosimilars under development
Exhibit 55: Key deals in global protein therapeutics market
Exhibit 56: Market presence of vendors in various therapy areas 2015
Exhibit 57: Competitive assessment of vendors
Exhibit 58: Geographical presence of key vendors
Exhibit 59: F. Hoffmann-La Roche: Profile
Exhibit 60: F. Hoffmann-La Roche: Strength assessment
Exhibit 61: F. Hoffmann-La Roche: Strategy assessment
Exhibit 62: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 63: Novo Nordisk: Profile
Exhibit 64: Novo Nordisk: Strength assessment
Exhibit 65: Novo Nordisk: Strategy assessment
Exhibit 66: Novo Nordisk: Opportunity assessment
Exhibit 67: Amgen: Profile
Exhibit 68: Amgen: Strength assessment
Exhibit 69: Amgen strategy assessment
Exhibit 70: Amgen: Opportunity assessment
Exhibit 71: AbbVie: Profile
Exhibit 72: AbbVie: Strength assessment
Exhibit 73: AbbVie: Strategy assessment
Exhibit 74: AbbVie: Opportunity assessment
Exhibit 75: Johnson & Johnson: Profile
Exhibit 76: Johnson & Johnson: Strength assessment
Exhibit 77: Johnson & Johnson: Strategy assessment
Exhibit 78: Johnson & Johnson: Opportunity assessment
Exhibit 79: Merck: Profile
Exhibit 80: Merck: Strength assessment
Exhibit 81: Merck: Strategy assessment
Exhibit 82: Merck: Opportunity assessment
【レポート販売概要】
■ タイトル：蛋白質治療の世界市場2017-2021：mAbs、ヒトインスリン、凝固因子、EPO、ヒト成長ホルモン■ 英文：Global Protein Therapeutics Market 2017-2021
■ 発行日：2016年12月29日
■ 調査会社：Technavio
■ 商品コード：IRTNTR11316
■ 調査対象地域：グローバル
- デジタルボールトの世界市場予測（～2023年）The global digital vault market size to grow at a CAGR of 13.6% during the forecast periodThe digital vault market size is expected to grow approximately from USD 471 million in 2018 to USD 892 million by 2023, at a Compound Annual Growth Rate (CAGR) of 13.6% during the forecast period. The increasing regulations and compliances to protect sensitive data, and rising concerns for protecting data fr …
- Gastar Exploration Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Gastar Exploration Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Gastar Exploration Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
- 3Dプリントヘルスケアの世界市場：コンポーネント別、技術別、用途別、エンドユーザー別3D printing, also known as desktop fabrication or additive printing technology, allows manufacturers to develop objects using a digital file and various printing materials. The materials used in 3D printing include several types of polymers, metals, and ceramics. 3D printing offers methodologies that can make manufacturing of complex designs an apparent reality. The 3D printing technology in healt …
- コンタクトレンズの世界市場予測（～2023年）“The global contact lenses market projected to grow at a CAGR of 4.9%.”The global contact lenses market is projected to reach USD 9.2 billion by 2023 from an estimated USD 7.2 billion in 2018, growing at a CAGR of 4.9% from 2018 to 2023. Growing prevalence of myopia, growing geriatric population, and increasing preference for contact lenses over prescription eyeglasses are the major factors drivin …
- Ongoing Studies and Demo Projects Point toward India’s Massive Smart Grid PlansOngoing Studies and Demo Projects Point toward India’s Massive Smart Grid Plans Summary The Government of India (GoI) came up with the Restructured Accelerated Power Development and Reforms Program (R-APDRP) in 2008 for transforming the power distribution sector in India. Through R-APDRP, distribution utilities plan of building Information Technology (IT) infrastructure, IT applications and automa …
- 女性医療診断の世界市場ABSTRACTAbout Women's Health Diagnostics Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have …
- 展開再生医療の世界市場展望：幹細胞治療、組織工学、遺伝子治療What can be expected from the Translational Regenerative Medicine market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there. Our 285-page report provides 170 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new st …
- 自動車用空気清浄機の世界市場2020-2024Global Car Air Purifier Market 2020-2024 Technavio has been monitoring the global car air purifier market and it is poised to grow by USD 884.85 mm during 2020-2024, progressing at a CAGR of 9% during the forecast period. Our reports on car air purifier market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around …
- Biomet, Inc.：市場シェア分析Biomet, Inc. Market Share Analysis Summary GlobalData’s new report, “Biomet, Inc. Market Share Analysis” provides in-depth information on Biomet, Inc.’s market position in the different medical equipment markets it operates in. The report provides Biomet, Inc. market share information in 10 key market categories – Other Joint Reconstruction, Knee Reconstruction, Cranio Maxillofacial Fixation (CMF) …
- French Flow Cytometry Market 2014: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive LandscapeComplete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the French flow cytometry market, including:Major issues pertaining to the French flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year …
- 世界のCEP（複合イベント処理）市場：Global Complex Event Processing (CEP) Market 2014-2018TechNavio's analysts forecast the Global Complex Event Processing market to grow at a CAGR of 26.51 percent over the period 2014-2018. One of the key factors contributing to this market growth is the increasing need for fast access to data. The Global Complex Event Processing market has also been witnessing the emergence of SaaS-based CEP Software. However, the high cost of implementation could po …
- レシチン及びリン脂質のグローバル市場動向（～2019）Lecithin and phospholipids are one of the fastest growing ingredient markets. The increasing consumption for convenience foods, supplements and nutrients, and the growing demand for natural food are the drivers for the lecithin and phospholipids market. This report estimates the lecithin & phospholipids market size. In terms of geography, the report is segmented into Asia-Pacific, Europe, North Am …
- 世界の人材管理市場動向（2012-2016）TechNavio's analysts forecast the Global Human Capital Management market to grow at a CAGR of 10.05 percent over the period 2012-2016. One of the key factors contributing to this market growth is the streamlining of human resource operations. The Global HCM market has also been witnessing the emergence of SaaS-based HCM solutions. However, the fragmentation of the market could pose a challenge to …
- 髄膜炎(Meningitis)：世界の治験レビュー2014年下半期版Meningitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- Safinamide (パーキンソン病)：医薬品市場予測及び分析（～2022）Safinamide (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly …
